학술논문

A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: The TUCC trial
Document Type
Journal
Source
AMERICAN HEART JOURNAL; AUG 2001, 142 2, p244-p247, 4p.
Subject
Language
English
ISSN
00028703